Improvement of in vitro two-stage transformation assay and determination of the promotional effect of cadmium

被引:22
作者
Fang, MZ
Kim, DY
Lee, HW
Cho, MH [1 ]
机构
[1] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Suwon 441744, South Korea
[2] Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea
[3] Sungkyunkwan Univ, Coll Med, Suwon 440746, South Korea
关键词
cadmium; in vitro two-stage transformation;
D O I
10.1016/S0887-2333(01)00012-1
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The classical in vitro two-stage transformation method wa:; modified for high transformation frequency, and the promotional effect of cadmium was evaluated. In this study, we reconfirmed the usefulness of the replating method and the optimal duration time between the initiator and promoter treatments for the optimal transformation of the Balb/3T3 cells. The results also showed that subsequent exposure to CdCl2 for 2 weeks after initial exposure to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) markedly enhanced the transformation frequency. At the concentration of 360 ng/ml, the transformation frequency was increased by 35-fold that of the cultures treated only with MNNG, and was higher than that of the positive control group treated with 100 ng/ml 12-O-tetradecanoyl phorbol-13-acetate (TPA) after MNNG treatment. This transformation frequency was higher than that reported previously. Therefore, this in vitro two-stage transformation method can be used efficiently for the screening of genotoxic and nongenotoxic carcinogens and the study of multistage carcinogenesis. These results also indicate that cadmium has a strong potency as a promoter, and the promotional effect of cadmium is higher than that of TPA. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 30 条
[1]   In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo [J].
Abshire, MK ;
Devor, DE ;
Diwan, A ;
Shaughnessy, JD ;
Waalkes, MP .
CARCINOGENESIS, 1996, 17 (06) :1349-1356
[2]  
[Anonymous], 1993, INT AGENCY RES CANC, V58, P119
[3]  
BARRETT J C, 1984, Pharmacological Reviews, V36, p53S
[4]  
CHO JH, 1997, TOXICOLOGIST, V36, P58
[5]   Enhancement of BALB/c 3T3 cells transformation by 1,2-dibromoethane promoting effect [J].
Colacci, A ;
Vaccari, M ;
Perocco, P ;
DaVia, C ;
Silingardi, P ;
Manzini, E ;
Horn, W ;
Grilli, S .
CARCINOGENESIS, 1996, 17 (02) :225-231
[6]  
FANG MZ, 2001, IN PRESS TOXICOLOGY
[7]  
FUJIMURA S, 1970, CANCER RES, V30, P1444
[8]  
Goering PL., 1995, Handbook of Experimental Pharmacology, V115, P189, DOI DOI 10.1007/978-3-642-79162-8_9
[9]  
HARRIS CC, 1991, CANCER RES, V51, pS5023
[10]  
IARC, 1976, MON EV CARC RISKS HU, V11, P39